Vidyasagar Pradeep Vuligonda

This inventor holds 86 USPTO granted patents and 2 published patent applications and 2 EPO patents, primarily in Retinoid Research (CPC class C07D-). Top assignees: Allergan, Inc., Allergan Sales, Inc., Io Therapeutics, Inc.. Active years: 1996-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vidyasagar Pradeep Vuligonda. Retrieved from https://idiyas.com/inventor/vidyasagar-pradeep-vuligonda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 86 (Patent Applications = 2)

% Patents Active = 84.9

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 4.2

ph-index = 35

Forward Citations = 2,214(Granted Patents)

Forward Citations (Not Self Cited) = 1,869(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Irvine, CA (US) (1996 - 2021)
Lake Forest, CA (US) (2023)
Spring, TX (US) (2024)

Company Filing History:

Io Therapeutics, Inc.

patents

4. 2 out of 834,570

Other

patents

Years Active: 1996-2025

Loading Chart...

Areas of Expertise:

Retinoid Compounds

RXR Agonists

Cancer Treatment

Dihydronaphthalene

Formyl Peptide Modulators

Selective Cytochrome P450

Biological Activity

Antagonist Activity

Receptor Modulators

Polymorphs

Synthesis Methods

86 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12325685 - RXR agonist salt form, polymorphs thereof, and uses thereof (2025-06-10),

2. 12115193 - Methods of using RARγ agonists for cancer treatment (2024-10-15),

3. 11976021 - Synthesis of tetrahydronaphthalenols and uses thereof (2024-05-07),

4. 11919848 - RXR agonist salt form, polymorphs thereof, and uses thereof (2024-03-05),

5. 11793835 - Methods of using RARγ agonists for cancer treatment (2023-10-24),

6. 10919835 - Compounds and synthetic methods for the preparation of retinoid X receptor-specific retinoids (2021-02-16),

7. 10590059 - Compounds and synthetic methods for the preparation of retinoid X receptor-specific retinoids (2020-03-17),

8. 9920013 - 2,5-dioxoimidazolidin-1-yl-3-urea derivatives as formyl peptide modulators (2018-03-20),

9. 9868700 - Carbamoyl hydrazine derivatives as formyl peptide modulators (2018-01-16),

10. 9663457 - Carbamoyl hydrazine derivatives as formyl peptide modulators (2017-05-30),

11. 9604934 - Urea hydantoin derivatives as formyl peptide modulators (2017-03-28),

12. 9090624 - Aromatic bycyclic derivatives as CXCR4 receptor modulators (2015-07-28),

13. 8846760 - Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators (2014-09-30),

14. 8729096 - Imidazolidine-2,4-dione derivatives as N-formyl peptide receptor 2 modulators (2014-05-20),

15. 8653299 - Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators (2014-02-18),

Title: The Innovative Journey of Vidyasagar Pradeep Vuligonda

Introduction:

Vidyasagar Pradeep Vuligonda, a prolific inventor based in Irvine, CA, has made remarkable contributions to the field of pharmaceuticals with a total of 84 patents to his name. His groundbreaking work continues to shape the industry and pave the way for new advancements.

Latest Patents:

Among his latest patents is the groundbreaking "Synthesis of tetrahydronaphthalenols and uses thereof," which outlines compounds and synthetic methods vital for preparing tetrahydronaphthalenol derivatives. Additionally, he holds a patent for "RXR agonist salt form, polymorphs thereof, and uses thereof," showcasing his expertise in creating new salt and solid forms of pharmaceutical compounds with diverse applications.

Career Highlights:

Vidyasagar Pradeep Vuligonda has left an indelible mark through his tenure at reputed companies like Allergan, Inc. and Allergan Sales, Inc. His innovative spirit and dedication to scientific exploration have been instrumental in driving cutting-edge research and development initiatives within the pharmaceutical sector.

Collaborations:

Throughout his career, Vidyasagar Pradeep Vuligonda has collaborated with esteemed professionals such as Roshantha A Chandraratna and Richard L Beard. These collaborations have not only enhanced the quality of his work but also led to the formation of invaluable partnerships that have pushed the boundaries of innovation in the pharmaceutical realm.

Conclusion:

In conclusion, Vidyasagar Pradeep Vuligonda's journey as an inventor exemplifies a commitment to excellence, creativity, and pushing the boundaries of scientific discovery. His extensive patent portfolio and significant contributions to the field underscore his status as a visionary in the realm of pharmaceutical innovation, inspiring future generations of inventors to continue pushing the limits of what is possible in the pursuit of scientific advancement.

Profile summary based on public USPTO records.